Bioton S.a.
BIO
Rank in Stocks
#20900
Bioton S.A. operates as a biotechnology company, engaged in the creation,... Bioton S.A. operates as a biotechnology company, engaged in the creation, production, distribution, and commercialization of a diverse array of pharmaceuticals, medicinal preparations, and active pharmaceutical ingredients. Its primary focus is on diabetes management, offering products such as recombinant human and conventional insulin, alongside oral anti-diabetic medications. The company's portfolio extends to include dietary supplements, blood glucose monitoring strips, and over-the-counter solutions for diabetics. Key insulin products include Gensulin N, Gensulin R, and Gensulin M30, available in vials and cartridges. Complementing these are advanced delivery and monitoring systems like the GensuPen 2 automatic injection device and the GensuCare glucometer for diabetes monitoring, alongside essential needles. Bioton S.A. distributes its offerings across numerous international markets, including Poland, China, Thailand, Vietnam, Libya, Argentina, Ukraine, Malta, Yemen, and the Russian Federation. Beyond its core product activities, the company also undertakes advertising, advisory services, and general corporate management. Founded in 1989, its headquarters are situated in Ozarów Mazowiecki, Poland.
Share Price
$0.89290853
Last synced: 2026-11-09
Market Cap
$76.67M
Change (1 day)
1.75%
Change (1 year)
-22.28%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Bioton S.a. (BIO)
Category
Healthcare
Operating Margin for Bioton S.a. (BIO)
Operating Margin as of November 2026 TTM: 6.03%
According to Bioton S.a.'s latest financial reports, its current operating margin (TTM) is 6.03%. At the end of 2025 the company had an operating margin of 4.53%.
Operating Margin history for Bioton S.a. from 2005 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 6.03% | 33.11% |
| 2025 | 4.53% | -264.73% |
| 2024 | -2.75% | -132.66% |
| 2023 | 8.42% | -7.68% |
| 2022 | 9.12% | 3.64% |
| 2021 | 8.80% | -59.82% |
| 2020 | 21.90% | -377.57% |
| 2019 | -7.89% | -63.69% |
| 2018 | -21.73% | -535.47% |
| 2017 | 4.99% | -199.80% |
| 2016 | -5.00% | -95.98% |
| 2015 | -124.34% | -2,221.84% |
| 2014 | 5.86% | 83.13% |
| 2013 | 3.20% | -80.58% |
| 2012 | 16.48% | -193.27% |
| 2011 | -17.67% | -186.49% |
| 2010 | 20.43% | -110.30% |
| 2009 | -198.39% | 714.41% |
| 2008 | -24.36% | -165.86% |
| 2007 | 36.99% | 6.48% |
| 2006 | 34.74% | 26.24% |
| 2005 | 27.52% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -93.60% |
US
|
|
| -149.01% | -124.71% |
US
|
|
| 25.57% | -95.76% |
AU
|
|
| 31.23% | -94.82% |
BE
|
|
| 29.35% | -95.13% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Bioton S.a.'s operating margin
What is Bioton S.a.'s operating margin?
Bioton S.a.'s operating margin is 6.03%, as of Nov 2026.
What was Bioton S.a.'s operating margin in 2025?
In 2025, Bioton S.a.'s operating margin was 4.53%, compared with -2.75% in 2024.
How has Bioton S.a.'s operating margin changed since 2020?
From 2020 to 2025, Bioton S.a.'s operating margin was highest in 2020 (21.90%) and lowest in 2024 (-2.75%).
How does Bioton S.a.'s operating margin compare with similar companies?
Bioton S.a.'s operating margin (6.03%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.